dostarlimab
gsk
[]
 very promising. highlights and validates the strong effects of very high mutational and neoantigen load in settings prior to stage 4! looking forward to seeing the phase 3 results!
Chair, Immunotherapy Center, Cleveland Clinic Health System, @ClevelandClinic; Professor; fan of tennis, coral reefs, and Lego building;  views my own